Nicholas Cheng

M.Sc. Candidate

Nick is currently enrolled as a M.Sc. student at the University of Waterloo, within the School of Pharmacy. Nick completed his undergraduate degree in Biochemistry and Biotechnology at Wilfrid Laurier University, a program that focuses on health and pharmaceutical science. He is currently working on the development of a universal coronavirus vaccine with the Theraphage Lab. Nick is also the president of Evolv Biotech Inc, a start-up focusing on serum generation, bioplastic formulation, fertilizer production, and quantum dot creation.

Education

B.Sc. Honours in Biochemistry and Biotechnology, Sir Wilfrid Laurier University (2022)

Contact

nicholas.cheng@theraphage.bio
n29cheng@uwaterloo.ca

Presentations:

Cheng, N. R. Development of a Synthetic Virus-Like particle as a universal coronavirus vaccine. Presented at: University of Waterloo Bioworks Conference. 2024, January; Waterloo, ON.
Cheng, N. R. A Universal Coronavirus Vaccine: Is it possible? Presented at: University of Waterloo Big Bang Research Day. 2023, October; University of Waterloo, Waterloo, ON.